Literature DB >> 19871174

THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY.

T Shedlovsky1, J E Smadel.   

Abstract

Virus-free filtrate, obtained from suspensions of vaccine virus-infected dermal pulp of rabbits and rich in the soluble substances of vaccinia, was shown to contain four distinct components in electrophoresis experiments. Electrophoretic and serological observations served as a guide in developing a method for separating these components from one another. This method depended upon changes in the solubilities of the components with alterations of pH. Three of the four components appeared to be serologically inert when tested with anti-vaccinia sera. All of the L- and S-activity was found to be associated with a single component which was electrically homogeneous at several values of pH and which was homogeneous in the ultracentrifuge. This single substance, designated as LS-antigen, precipitates in equal titers with optimal amounts of L- and of S-antibody and is completely removed from solution by absorption with either antibody. The LS-antigen of vaccinia appears to be a protein molecule with two antigenically distinct parts, L and S. Heating modifies the L-portion in such a manner that the substance no longer precipitates with L-antibody; this degraded antigen still combines with L-antibody, as is shown by inhibition tests, and still precipitates with S-antibody. Similarly, treatment with heat and dilute alkali modifies the S-portion of LS-antigen so that it combines but does not precipitate with S-antibody; and at the same time all recognizable immunological properties of the L-portion are destroyed.

Entities:  

Year:  1942        PMID: 19871174      PMCID: PMC2135242          DOI: 10.1084/jem.75.2.165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker
Journal:  J Exp Med       Date:  1938-02-28       Impact factor: 14.307

2.  THE LS-ANTIGEN OF VACCINIA : I. INHIBITION OF L- AND S-ANTIBODIES BY SUBSTANCES IN TREATED VACCINE DERMAL FILTRATE.

Authors:  J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

3.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : VI. ISOLATION OF A HEAT-STABLE, SEROLOGICALLY ACTIVE SUBSTANCE FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

4.  STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : II. THE SOLUBLE PRECIPITABLE SUBSTANCES OF DERMAL VACCINE.

Authors:  J Craigie; F O Wishart
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

5.  ELECTROPHORETIC PATTERNS OF NORMAL AND PATHOLOGICAL HUMAN BLOOD SERUM AND PLASMA.

Authors:  L G Longsworth; T Shedlovsky; D A Macinnes
Journal:  J Exp Med       Date:  1939-09-30       Impact factor: 14.307

  5 in total
  10 in total

1.  [Experimental studies of hemagglutinating principle in animal pox viruses].

Authors:  A MAYR
Journal:  Arch Gesamte Virusforsch       Date:  1956

2.  [Virus diseases in otorhinolaryngology region].

Authors:  R HAAS
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

3.  THE LS-ANTIGEN OF VACCINIA : III. PHYSICAL-CHEMICAL PROPERTIES OF LS-ANTIGEN AND SOME OF ITS DEGRADATION PRODUCTS.

Authors:  T Shedlovsky; A Rothen; J E Smadel
Journal:  J Exp Med       Date:  1943-02-01       Impact factor: 14.307

4.  Physico-chemical properties of some vaccinial immunoprecipitinogens.

Authors:  J Marquardt; E Falsen; E Lycke
Journal:  Arch Gesamte Virusforsch       Date:  1969

5.  Demonstration of the sequential development of vaccinial antigens and virus in infected cells: observations with cytochemical and differential fluorescent procedures.

Authors:  P C LOH; J L RIGGS
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

6.  The protein coats or ghosts of coli phage T2. II. The biological functions.

Authors:  R M HERRIOTT; J L BARLOW
Journal:  J Gen Physiol       Date:  1957-11-20       Impact factor: 4.086

7.  THE LS-ANTIGEN OF VACCINIA : I. INHIBITION OF L- AND S-ANTIBODIES BY SUBSTANCES IN TREATED VACCINE DERMAL FILTRATE.

Authors:  J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

8.  THE LS-ANTIGEN OF VACCINIA : IV. CHEMICAL ANALYSIS OF LS AND THE EFFECT OF CHYMOTRYPSIN ON LS.

Authors:  J E Smadel; C L Hoagland; T Shedlovsky
Journal:  J Exp Med       Date:  1943-02-01       Impact factor: 14.307

9.  MORPHOLOGICAL STRUCTURE OF THE VIRUS OF VACCINIA.

Authors:  R H Green; T F Anderson; J E Smadel
Journal:  J Exp Med       Date:  1942-06-01       Impact factor: 14.307

10.  Sustained hyperlipemia induced in rabbits by means of intravenously injected surface-active agents.

Authors:  A KELLNER; J W CORRELL; A T LADD
Journal:  J Exp Med       Date:  1951-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.